AVITA Medical Inc
NASDAQ:RCEL
AVITA Medical Inc
NASDAQ:RCEL
Price:
3.95
USD
0.51%
Market Closed
Market Cap:
$120.4m
Cash Flow Statement
Cash Flow Statement
AVITA Medical Inc
AVITA Medical Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(27)
|
(22)
|
(14)
|
(29)
|
(30)
|
(30)
|
(27)
|
(26)
|
(31)
|
(34)
|
(35)
|
(45)
|
(50)
|
(57)
|
(62)
|
(57)
|
(52)
|
(49)
|
|
| Depreciation & Amortization |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Stock-Based Compensation |
6
|
4
|
4
|
10
|
10
|
9
|
7
|
5
|
5
|
6
|
8
|
8
|
11
|
13
|
14
|
14
|
12
|
11
|
|
| Other Non-Cash Items |
7
|
6
|
4
|
9
|
9
|
8
|
8
|
8
|
8
|
9
|
3
|
4
|
5
|
9
|
16
|
15
|
14
|
14
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
5
|
5
|
5
|
6
|
5
|
|
| Change in Working Capital |
(7)
|
(3)
|
5
|
0
|
2
|
0
|
(1)
|
(1)
|
(2)
|
(6)
|
(7)
|
(9)
|
(9)
|
(4)
|
(5)
|
2
|
0
|
(1)
|
|
| Cash from Operating Activities |
(26)
N/A
|
(19)
+28%
|
(6)
+71%
|
(19)
-242%
|
(18)
+2%
|
(21)
-12%
|
(19)
+7%
|
(19)
+2%
|
(24)
-30%
|
(31)
-25%
|
(38)
-24%
|
(50)
-31%
|
(53)
-7%
|
(52)
+3%
|
(49)
+5%
|
(38)
+22%
|
(36)
+7%
|
(34)
+6%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(5)
|
(8)
|
(9)
|
(8)
|
(6)
|
(3)
|
|
| Other Items |
0
|
(50)
|
(50)
|
(72)
|
(57)
|
(16)
|
(19)
|
23
|
26
|
57
|
3
|
0
|
(3)
|
(15)
|
47
|
41
|
34
|
18
|
|
| Cash from Investing Activities |
(1)
N/A
|
(51)
-4 217%
|
(50)
+2%
|
(72)
-46%
|
(58)
+21%
|
(16)
+72%
|
(19)
-19%
|
22
N/A
|
26
+16%
|
56
+117%
|
2
-97%
|
(2)
N/A
|
(8)
-280%
|
(22)
-179%
|
37
N/A
|
33
-12%
|
28
-16%
|
15
-46%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
69
|
69
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
4
|
3
|
3
|
17
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
39
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Cash from Financing Activities |
64
N/A
|
64
N/A
|
0
-100%
|
0
+471%
|
0
-75%
|
0
N/A
|
1
+8 900%
|
1
+19%
|
1
+16%
|
2
+48%
|
40
+2 094%
|
41
+1%
|
42
+2%
|
42
+1%
|
4
-92%
|
3
-8%
|
3
-9%
|
16
+433%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
37
N/A
|
(5)
N/A
|
(55)
-946%
|
(91)
-65%
|
(76)
+17%
|
(37)
+52%
|
(38)
-2%
|
4
N/A
|
3
-41%
|
27
+960%
|
4
-85%
|
(11)
N/A
|
(20)
-80%
|
(32)
-61%
|
(8)
+75%
|
(2)
+74%
|
(5)
-152%
|
(3)
+39%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(27)
N/A
|
(20)
+27%
|
(6)
+71%
|
(19)
-241%
|
(19)
+2%
|
(21)
-12%
|
(20)
+7%
|
(19)
+0%
|
(25)
-29%
|
(32)
-26%
|
(39)
-24%
|
(52)
-32%
|
(58)
-12%
|
(60)
-3%
|
(58)
+2%
|
(47)
+20%
|
(42)
+10%
|
(37)
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
